Trials / Completed
CompletedNCT02439190
CV004-007 Thrombosis Chamber Study
A Single Dose Study to Evaluate the Effect of BMS-986120 on Thrombus Formation in an Ex Vivo Thrombosis Chamber Model in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether BMS-986120, aspirin, or aspirin and clopidogrel decrease blood clotting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986120 | |
| DRUG | Aspirin | |
| DRUG | Clopidogrel |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2015-05-08
- Last updated
- 2016-09-08
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02439190. Inclusion in this directory is not an endorsement.